on Thursday, October 11, 2012
Good Morning America co-host Robin Roberts recently said good-bye to her inpatient treatment team at Memorial Sloan Kettering after undergoing a stem cell transplant to treat myelodysplastic syndrome.
Good Morning America co-host Robin Roberts recently said good-bye to her Memorial Sloan Kettering inpatient treatment team, after being hospitalized for several weeks and receiving a stem cell transplant for the treatment of myelodysplastic syndrome (MDS). Ms. Roberts, who will continue to be followed closely as an outpatient, thanked her team of doctors, nurses, and staff who cared for her under the leadership of Sergio Giralt, Chief of the Adult Bone Marrow Transplantation Service.
Ms. Roberts had been diagnosed with MDS, which arises in the bone marrow due to a disorder of hematopoietic stem cells, the immature cells from which all blood cells develop. Her treatment involved a transplant of healthy stem cells from a donor – known as an allogeneic stem cell transplant.
Ms. Roberts recently told Good Morning America that “My doctors and rock star nurses are very pleased with my progress, and I could not be more thankful for the excellent care I am receiving.”
To learn more about stem cell transplantation, read a Q&A from experts on our Adult Bone Marrow Transplantation Service about the procedure, the recovery process, and how to become a bone marrow or stem cell donor.
Visit Good Morning America to watch a video of Robin Roberts’s journey at Memorial Sloan Kettering.